Robbins LLP Urges UNCY Stockholders with Significant Losses to Contact the Firm for Information About the Unicycive Therapeutics, Inc. Class Action
Robbins LLP issued a solicitation reminding UNCY investors of a securities class action covering purchasers between December 29, 2025 and June 29, 2026, with a November 2, 2026 lead plaintiff deadline. The suit alleges Unicycive failed to inspect its third-party manufacturing vendor's facility, and the FDA issued a second Complete Response Letter for oxylanthanum carbonate citing the same deficiencies as the June 2025 CRL.
Key figures
- Stock drop pct
- 39.1%
- Post drop close
- $4.69
- Class period end
- 2026-06-29
- Stock drop amount
- $3.01
- Class period start
- 2025-12-29
- Lead plaintiff deadline
- 2026-11-02
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.